The FTC opened an investigation in June 2022 into six large PBMs: CVS Caremark, Express Scripts, OptumRx, Humana, Prime ...
The news comes just one day after the FTC announced it had completed a two-year investigation into the industry. Pharmacy ...
Preparations to sue follow a two-year probe into whether the firms steer patients away from less-expensive medicines.
Federal regulators plan to sue the top three pharmacy-benefit managers over how they negotiate prices for drugs, including ...
Antitrust regulators are set to file suit against CVS Caremark, Express Scripts and Optum Rx over how they negotiate discounts for drugs, including insulin, per the report.
Eli Lilly inked a $140 million upfront deal with Radionetics Oncology. Merit Medical will acquire EndoGastric Solutions for ...
The U.S. District Court for the District of New Jersey’s recent decision in Teva v. Amneal 1 elaborates on the standard ... and method of use patents. 17 Amneal and the FTC contended the patents at ...
National Heat Protections Proposed: Following California's lead, the Biden administration on Tuesday announced that it will advance a proposed rule to protect indoor and outdoor workers from high ...
A Georgia chiropractor admitted to nearly $15 million in healthcare fraud related to a kickback scheme involving durable ...
The Federal Trade Commission has ordered Teva Pharmaceuticals to provide internal documents about its patents on asthma and COPD inhalers. The move is part of a larger dispute over minor tweaks made ...
The health industry remains on high alert after the scheme, which appeared to involve companies using personal data from hundreds of thousands of patients.
The FTC is formally investigating Teva Pharmaceuticals after it refused to remove certain patents for asthma and COPD ...